Drawing for THROMBOGENICS

USPTO serial 79081227

THROMBOGENICS

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
HAMPTON, CHARISMA
Law office
TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THROMBOGENICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa Greenwald-Swire

Lisa Greenwald-Swire Fish & Richardson P.C.P.O. Box 1022Minneapolis, MN 55440-1022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations and substances for use in the manufacture of pharmaceutical productsSECTION 70 - CANCELLED—
005Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biopharmaceutical preparations; diagnostic medical reagents, chemicals and biological materials both as spatially defined arrays and solutions or reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring or predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseasesSECTION 70 - CANCELLED—
042Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical and biopharmaceutical research and development; (bio)pharmaceutical product evaluation; research into treatment of cardio vascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticalsSECTION 70 - CANCELLED—
044Medical services; veterinary services; medical, veterinary and pharmaceutical advisory and consultancy services; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing servicesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
Nov 21, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 27, 2010DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 10, 2010RFNTREFUSAL PROCESSED BY IB—
May 7, 2010RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 7, 2010RFRRREFUSAL PROCESSED BY MPU—
May 7, 2010RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 6, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2010MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 30, 2010DOCKASSIGNED TO EXAMINER—
Apr 30, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 29, 2010REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance